Genome & Company: Stock Option Exercise Price Cut to 10,530 Won, Grant Shares Increased
-
Correction: Grantees reduced from 15 to 10, shares granted increased from 49,750 to 67,000.
-
Exercise price: Adjusted down 71% from 36,650 won to 10,530 won due to capital increases.
-
Total outstanding after grant surged from 1,941,396 to 4,092,568 shares.
-
Fair value per option slightly decreased from 18,433 to 18,144 won.
-
Exercise period unchanged: 2022.08.25~2029.08.24.
KOSDAQ Filing Information
-
Filing: [Correction of Description] Report on Grant of Stock Options
-
Company: Genome & (314130)
-
Submission: Genome & Company
-
Receipt: 05-14-2026